| Provenge Activists Try Again For FDA Documents | 11/20/2009 - 11:30 |
| 4-Star Stocks Poised to Pop: Merck | 11/20/2009 - 11:27 |
| Ten Minutes That Mattered: Gilead's Martin | 11/20/2009 - 08:38 |
| Opponents of Botox Tax Go Big: Baby Boomers! Women! | 11/20/2009 - 08:35 |
| Possible New Indication for Progenics' Relistor Could Revive Its Fortunes | 11/20/2009 - 08:28 |
| Secret Prempro Documents To Surface In Florida? | 11/20/2009 - 08:26 |
| Roche's Actemra successful in arthritis study | 11/20/2009 - 08:26 |
| Pfizer Is Best Positioned Big Pharma in China - Goldman | 11/20/2009 - 07:23 |
| Santarus' Zegrid Facing Back-to-Back FDA Approval Dates | 11/20/2009 - 06:51 |
| Genzyme: This Stock Is a Train Wreck | 11/20/2009 - 06:35 |
| U.S. House Votes to Avert Cuts in Medicare Payments to Doctors | 11/20/2009 - 06:34 |
| Pfizer Dodges a Bullet | 11/20/2009 - 06:32 |
| NeurogesX: Next Stop, U.S. Market | 11/19/2009 - 16:19 |
| Ligand Pharmaceuticals receives $2 million from research partnership with Merck | 11/19/2009 - 16:19 |
| Merck Gives Snapshot of Combined Company: $47B in Sales; Just $7.6B in Cash | 11/19/2009 - 15:39 |
| Big Pharma Under Pressure as Drug Patents Expire and Pipeline Slows | 11/19/2009 - 15:35 |
| FDA panel backs stronger benefit claims and safety profile for inhaler drug Spiriva | 11/19/2009 - 15:34 |
| Congress wants GAO to probe drug prices | 11/19/2009 - 10:40 |
| Plavix Label Change: Good For Effient Now, Bad For Brands in the Long Run? | 11/19/2009 - 10:33 |
| ImmuPharma CEO slams stock plunge after drug trial | 11/19/2009 - 10:30 |
| Poniard Pharmaceuticals' Gamble Doesn't Pay Off | 11/19/2009 - 10:29 |
| U.S. Sees Low Demand for BioCryst Flu Drug | 11/19/2009 - 10:28 |
| Genzyme Drops Kidney-Drug Plans Amid Pileup of Bad News | 11/19/2009 - 10:23 |
| Should You Buy It? Alkermes | 11/19/2009 - 09:58 |
| Flu Shot Made From Caterpillars May Win Pivotal U.S. Backing | 11/19/2009 - 09:56 |
| J&J vs. 10-Year T-Bonds: The Power of Rising Dividends | 11/19/2009 - 09:53 |
| Drug Lowers Cholesterol; Stock Follows | 11/19/2009 - 09:13 |
| Hard to Get Excited about BI's Flibanserin | 11/19/2009 - 09:09 |
| U.S. panel rejects Xolair asthma drug for children | 11/19/2009 - 09:08 |
| Sanofi-Aventis to launch antimalarial drug study | 11/19/2009 - 09:07 |
